Depression drug-maker Naurex picks up $80 mln Series C
Evanston, Illinois-based Naurex, a developer of drugs that treat depression and other central nervous system disorders, has closed $80 million in Series C funding.
3 December 2014•1 min read
Evanston, Illinois-based Naurex, a developer of drugs that treat depression and other central nervous system disorders, has closed $80 million in Series C funding.
